Cambridge Investment Research Advisors’s Nuveen Corporate Income November 2021 Target Term Fund JHB Stock Holding History

Cambridge Investment Research Advisors’s Portfolio JHB Stock Details JHB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-42,790	Closed	-$401K	–	3332
2021 Q3	$401K	Sell	42,790 -44,648	-51%	-$419K	﹤0.01%	2217
2021 Q2	$824K	Buy	87,438 +71,624	+453%	+$674K	﹤0.01%	1684
2021 Q1	$148K	Buy	+15,814	New	+$147K	﹤0.01%	2702

Cambridge Investment Research Advisors's JHB Position: Q4 2021 in Review

Cambridge Investment Research Advisors sold out of Nuveen Corporate Income November 2021 Target Term Fund (JHB) in Q4 2021, closing a stake of 42,790 shares — an estimated $401K sold.

Cambridge Investment Research Advisors first reported a position in JHB in Q1 2021 and held it in 3 quarters. The position peaked at $824K in Q2 2021. 0 funds tracked by Wall St. Rank hold JHB as of Q4 2021.

Cambridge Investment Research Advisors reported no remaining Nuveen Corporate Income November 2021 Target Term Fund position as of Q4 2021 after selling out during the quarter.
Cambridge Investment Research Advisors sold 42,790 Nuveen Corporate Income November 2021 Target Term Fund shares in Q4 2021, an estimated $401K.
Cambridge Investment Research Advisors first reported a position in Nuveen Corporate Income November 2021 Target Term Fund in Q1 2021 and held it in 3 quarters.
Cambridge Investment Research Advisors's Nuveen Corporate Income November 2021 Target Term Fund position peaked at $824K in Q2 2021.
0 funds tracked by Wall St. Rank held Nuveen Corporate Income November 2021 Target Term Fund as of Q4 2021.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.